National Clinical Research Center for Obstetrical and Gynecological Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Cancer Invasion and Metastasis, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
National Clinical Research Center for Obstetrical and Gynecological Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Cancer Invasion and Metastasis, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ageing Res Rev. 2023 Apr;86:101879. doi: 10.1016/j.arr.2023.101879. Epub 2023 Feb 8.
Uterine aging is an important factor that impacts fertility, reproductive health, and uterus-related diseases; however, it remains poorly explored. Functionally, these disturbances have been associated with an abnormal hormonal response in the endometrium and decreased endometrial receptivity. Based on emerging evidence, these alterations are mediated via the senescence of endometrial stem cells and impaired decidualization of endometrial stromal cells. Multiple molecular activities may participate in uterine aging, including oxidative stress, inflammation, fibrosis, DNA damage response, and cellular senescence. Over the past decade, several protective strategies targeting these biological processes have afforded promising results, including stem cell therapy, anti-aging drugs, and herbal medicines. However, the currently available evidence is fragmented and scattered. Here, we summarize the most recent findings regarding uterine aging, including functional and structural alterations and potential cellular and molecular mechanisms, and discuss potential protective interventions against uterine aging. Thereby, we hope to provide a comprehensive understanding of the pathophysiological processes and underlying mechanisms associated with uterine aging, as well as improve fecundity and reproductive outcomes in females of advanced reproductive age.
子宫衰老(aging)是影响生育力、生殖健康和与子宫相关疾病的重要因素,但目前对此知之甚少。从功能上讲,这些紊乱与子宫内膜的异常激素反应和子宫内膜容受性降低有关。基于新出现的证据,这些改变是通过子宫内膜干细胞的衰老和子宫内膜基质细胞的蜕膜化受损来介导的。多种分子活动可能参与子宫衰老,包括氧化应激、炎症、纤维化、DNA 损伤反应和细胞衰老。在过去的十年中,针对这些生物学过程的几种保护策略已经取得了有希望的结果,包括干细胞疗法、抗衰老药物和草药。然而,目前可用的证据是零碎和分散的。在这里,我们总结了关于子宫衰老的最新发现,包括功能和结构的改变以及潜在的细胞和分子机制,并讨论了针对子宫衰老的潜在保护干预措施。由此,我们希望全面了解与子宫衰老相关的病理生理过程和潜在机制,并改善高龄女性的生育能力和生殖结局。